Royal Bank Of Canada Arvinas, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Arvinas, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 7,416 shares of ARVN stock, worth $192,667. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,416

Previous 6,913 7.28%

Holding current value

$192,667

Previous $184,000 1.09%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$23.66 - $32.73 $11,900 - $16,463	503 Added 7.28%	7,416 $182,000
Q2 2024 Aug 14, 2024	BUY	$24.46 - $40.4 $127,999 - $211,413	5,233 Added 311.49%	6,913 $184,000
Q1 2024 Nov 05, 2024	SELL	$36.38 - $52.31 $190,376 - $273,738	-5,233 Reduced 75.7%	1,680 $69,000
Q1 2024 May 15, 2024	SELL	$36.38 - $52.31 $540,534 - $777,221	-14,858 Reduced 89.84%	1,680 $69,000
Q4 2023 Feb 14, 2024	BUY	$14.19 - $42.33 $133,783 - $399,087	9,428 Added 132.6%	16,538 $680,000
Q3 2023 Nov 14, 2023	BUY	$19.64 - $28.21 $60,962 - $87,563	3,104 Added 77.48%	7,110 $139,000
Q2 2023 Aug 14, 2023	SELL	$21.73 - $31.43 $17,405 - $25,175	-801 Reduced 16.66%	4,006 $99,000
Q1 2023 May 15, 2023	SELL	$26.15 - $37.26 $187,626 - $267,340	-7,175 Reduced 59.88%	4,807 $131,000
Q4 2022 Feb 14, 2023	BUY	$32.47 - $57.24 $349,117 - $615,444	10,752 Added 874.15%	11,982 $409,000
Q3 2022 Nov 14, 2022	BUY	$41.87 - $57.99 $14,068 - $19,484	336 Added 37.58%	1,230 $54,000
Q2 2022 Aug 15, 2022	SELL	$36.01 - $74.24 $91,825 - $189,312	-2,550 Reduced 74.04%	894 $37,000
Q1 2022 May 16, 2022	SELL	$60.27 - $81.57 $450,397 - $609,572	-7,473 Reduced 68.45%	3,444 $232,000
Q4 2021 Feb 14, 2022	BUY	$65.85 - $96.21 $436,190 - $637,295	6,624 Added 154.3%	10,917 $896,000
Q3 2021 Nov 15, 2021	BUY	$73.2 - $107.87 $95,452 - $140,662	1,304 Added 43.63%	4,293 $352,000
Q2 2021 Aug 16, 2021	BUY	$60.45 - $84.26 $180,685 - $251,853	2,989 New	2,989 $230,000

Others Institutions Holding ARVN

# of Institutions

229

Shares Held

68.4M

Call Options Held

226K

Put Options Held

285K

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.38B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Arvinas, Inc. Transaction History